61177-53-5Relevant articles and documents
HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
-
Page/Page column 110; 111, (2021/02/19)
The application relates to heterocyclic amide derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation. (Formula (I))
Adamantanamine derivatives, processes for their preparation and drugs in which they are present
-
, (2008/06/13)
The present invention relates to new adamantanamine derivatives. These derivatives correspond to the general formula I: STR1 in which: R represents hydrogen or a substituted or unsubstituted, linear or branched alkyl radical containing from 1 to 7 carbon